APA način citiranja

(2003). Oxybutynin is preferred to tolterodine for overactive bladder. BMJ Group.

Čikaški stil citiranja

Oxybutynin Is Preferred to Tolterodine for Overactive Bladder. BMJ Group, 2003.

MLA način citiranja

Oxybutynin Is Preferred to Tolterodine for Overactive Bladder. BMJ Group, 2003.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.